Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 14, 1984 - Issue 3
8
Views
1
CrossRef citations to date
0
Altmetric
Original Article

The metabolic fate of the herbicide nitralin in the rat

, &
Pages 221-233 | Received 28 Jun 1983, Published online: 30 Sep 2009
 

Abstract

1. 14C-Nitralin (4-methylsulphonyl-2,6-dinitro-N,N-dipropyl-[14Claniline) was dosed orally to rats (50mg/kg). The radioactivity was quantitatively recovered (99′8%) between 0 and 72 h after dosing. Most of this was distributed equally between the urine and the faeces; about 1·5% was found in the carcass, skin and intestines.

2. Structural analysis of the urinary metabolites showed that the metabolism proceeded via a complex multistep series of biotransformations involving nitro-group reduction, side-chain oxidation and removal and the subsequent formation of a variety of heterocyclic ring structures.

3. A major metabolite was 7-amino-2-ethyl-5-methylsulphonyl-l-propylbenzimi-dazole; however, this accounted for only three—four per cent of the ingested radioactivity and was one of about five metabolites produced in this yield. Seven other metabolites were identified, none of which was derived from single-step biotransformation of nitralin.

4. The latter, simpler, metabolites were detected on the incubation of nitralin with rat-liver enzymes of the type used in microbial mutagenicity testing. Two pathways (nitro-reduction and N-dealkylation) were observed under aerobic conditions but the former greatly predominated under anaerobic conditions.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.